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Abstract
Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian
H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants
investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative
human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in
the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan
array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual
binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naı ¨ve ferrets by respiratory droplets.
Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and
preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus
occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha
2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding
affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for
pandemic H2N2 influenza viruses.
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Introduction
Among the several known hemagglutinin (HA) and neuramin-
dase (NA) subtypes of influenza A viruses [1], only three subtypes
(H1N1, H2N2 and H3N2) have been documented to cause
widespread and sustained disease in humans. While H1N1 and
H3N2 subtypes continue to circulate in humans, the H2N2 Asian
pandemic virus of 1957/58 (responsible for approximately 2
million deaths globally), disappeared from the human population
after 1968 [2]. The 1957 pandemic H2N2 strain originated as a
reassortant in which a novel avian-like HA replaced the prevailing
human adapted H1 HA surface protein [3]. Genetic analysis of the
1957 strain and circulating avian H2 strains indicated that the
pandemic virus also acquired a novel polymerase subunit PB1
gene and NA gene from an influenza A virus of wild waterfowl
origin [4].
While much of the concerns of an influenza pandemic have
been due to exceptionally virulent strains of the H5N1 avian
influenza virus, there is also concern about the possibility of
pandemic virus recycling in humans [5,6]. More recently, this
concern has been heightened by the emergence of a novel H1N1
strain whose global spread and mortality rate prompted the World
Health Organization (WHO) to declare the first pandemic of the
21
st century [7]. Like the current pandemic H1N1 virus, certain
strains of H2 are swine-origin reassortant viruses containing genes
derived from avian and swine influenza viruses and appear to be
more adapted to mammals [8,9]. Due to the occurrence of several
genetic changes prior to displacement in the human population
around 1968, individuals born after that year lack specific B cell
immunity to the H2 HA [10]. Moreover, surveillance of influenza
viruses in avian species has provided evidence that H2 viruses are
isolated on a yearly basis and some avian H2N2 viruses,
circulating in wild and domestic birds, are antigenically similar
to the 1957 pandemic strain [11,12].
One of the characteristics of a pandemic influenza A virus is its
ability to transmit efficiently via respiratory droplets between
humans. We and others have made substantial effort to develop a
system using ferrets as a model to investigate both direct contact
and respiratory droplet transmission of influenza A viruses
[13,14,15,16]. We have further established a correlation between
transmissibility in ferrets and biochemical binding specificity of the
HA protein to sialylated glycan receptors for H1N1 viruses
[13,17,18]. The human adaptation of influenza A virus is
associated with the ability of the HA to change its binding
preference from glycan receptors present in the avian gastrointes-
tinal tract that consist of terminal a2,3-linked SA (referred to as
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that possess terminal a2,6-linked SA (referred to as a2,6)
[20,21,22]. In addition to adaptation of the HA, the adaptation
of the polymerase basic 2 (PB2) protein was recently found to be
necessary for influenza virus transmission in experimentally
inoculated mammals. In particular, the amino acids 627 and/or
701 of PB2 have been related to not only transmissibility but also
to replication efficiency of viruses [15,23].
Most of the above studies have focused on the H1N1, H3N2
and H5N1 subtypes, and very little on H2N2 viruses. The glycan
receptor binding preference of H2N2 viruses has been character-
ized using solid phase binding assays [24] and more recently using
crystal structures [25,26]. These studies point to the importance of
amino acid 226 in defining the binding specificity of HA to human
a2,6 or avian a2,3 glycan receptors. However, the transmissibility
of these viruses in the ferret model as it relates to glycan-receptor
binding preference has not been established. An understanding of
the mechanisms behind receptor binding preference and how this
property influences efficient virus transmission of pandemic strains
can aid in the surveillance and response to future outbreaks of
H2N2 viruses in the human population.
In this study, we used the ferret model that recapitulates the
efficient transmission of seasonal influenza viruses and the poor
transmission of avian influenza viruses in humans [13,14,15,16].
The glycan receptor binding preference of the H2N2 viruses was
characterized using agglutination of red blood cells (RBCs)
followed by a more extensive dose-dependent direct glycan array
binding assay. An avian H2N2 virus (A/Mallard/New York/
6750/78; Mallard/78) failed to spread efficiently to naı ¨ve ferrets,
whereas the human H2N2 Alb/58 virus spread efficiently by
respiratory droplet transmission. Although a 1957 isolate, ElSalv/
57, failed to spread efficiently to naı ¨ve ferrets, strikingly a natural
variant was isolated from one of the contact ferrets in a rare
transmission event and showed improved transmission to naı ¨ve
ferrets compared to the wild type virus. Characterization of the
H2N2 variant revealed a key mutation (glutamine to leucine at
position 226) in the HA that was sufficient to change its receptor
preference from a2,3 to a2,6 SA.
Results
We selected two human H2N2 viruses, ElSalv/57 and Alb/58
that were isolated during the Asian pandemic of 1957/58. ElSalv/
57 virus was isolated from the Southern hemisphere in the first
year of the pandemic whereas Alb/58 virus was isolated in 1958
from the Northern hemisphere. We also selected Mallard/78,
which is among the first avian H2N2 viruses isolated in the late
1970s as a representative avian virus for the transmission studies.
Transmissibility of avian Mallard/78 virus
The ferret model was used to evaluate the pathogenesis and
transmissibility of selected H2N2 influenza viruses. For respiratory
droplet transmission experiments, three animals were inoculated
i.n. with 10
6 plaque forming units (PFU) of virus. Approximately
24 hours later, inoculated-contact animal pairs were established by
placing a naı ¨ve ferret in each of three adjacent cages with
perforated side walls, allowing exchange of respiratory droplets in
the absence of direct or indirect contact [16]. Transmission was
assessed by titration of infectious virus in nasal washes and
detection of virus specific antibodies in convalescent serum. Ferrets
inoculated with the avian Mallard/78 virus did not cause any
visible clinical symptoms or significant weight loss and failed to
transmit by respiratory droplets, despite efficient replication in the
ferret upper respiratory tract of inoculated animals (Figure 1A).
Virus titers in the nasal washes of inoculated ferrets achieved peak
mean titers of 10
7.3 EID50/ml on day four post inoculation (p.i.)
(Table 1). Sneezing was not observed at any time point among the
three inoculated ferrets. These results indicate that, like avian
influenza viruses of other subtypes, the avian H2N2 virus failed
to transmit efficiently between ferrets by means of respiratory
droplets.
Mallard/78 virus was examined further for its ability to transmit
under conditions where ferrets were housed together in the same
cage (direct contact transmission). Virus titers in the nasal washes
of inoculated ferrets achieved peak mean titers of 10
6.25 EID50/ml
on day 2 p.i. (Table 1, Figure 1B). Transmission of Mallard/78
virus was inefficient as virus was detected in the nasal washes of
only one of three contact ferrets and transmission was confirmed
by seroconversion to the inoculating strain (Table 1). Sneezing was
present in only one (on a single day) out of three Mallard/78 virus-
inoculated ferrets and the paired ferret for that particular cage was
positive for Mallard/78 virus on day 4 post-contact (p.c.).
Transmissibility of human H2N2 viruses
Ferrets inoculated with Alb/58 virus generally displayed 7–9%
mean maximum weight loss and some lethargy at the height of
virus infection. Five out of six ferrets recovered fully from
inoculation; however, one Alb/58-inoculated ferret died on day
8 p.i. after exhibiting respiratory signs (sneezing and nasal
discharge) and 13% weight loss shortly before death (Table 1,
Figure 2A and B). Alb/58 virus achieved peak mean nasal wash
titers of 10
6.2 to 10
5.9 EID50/ml and had sustained titers of $10
4.0
EID50/ml for 6 days p.i. Sneezing was observed among the
majority of Alb/58 inoculated ferrets and the virus transmitted
efficiently by respiratory droplet as well as by direct contact
transmission (Figures 2A and 2B). Virus was detected in the nasal
washes of the contact ferrets between 1 to 3 days p.c. and all
animals seroconverted to Alb/58 virus (Table 1). These results
show that similar to other human influenza viruses, the human-
adapted H2N2 Alb/58 virus was capable of efficient transmission
to naı ¨ve ferrets by both direct contact and respiratory droplets.
Ferrets inoculated with ElSalv/57 virus exhibited mild lethargy
and weight loss similar to Alb/58-inoculated ferrets. Sneezing was
present in only one of six ElSalv/57-inoculated ferrets (sneezing in
one animal on day 4 p.i.) (Table 1). ElSalv/57 virus reached
similar peak titers as the Alb/58 virus in nasal washes (peak titers,
EID50/ml=10
6.5–7.0), however ElSalv/57 virus did not transmit
efficiently by respiratory droplets and failed to transmit by direct
contact as evidenced by the paucity of virus shedding and
seroconversion among the contact ferrets (Figures 2C and D,
Table 1). Remarkably, virus was detected in the nasal washes of
one of the respiratory droplet contact ferrets late in the course of
the experiment (Figure 2C). Seroconversion occurred in this
contact ferret (ferret # 3) as well as in all three inoculated ferrets
(Table 1). This isolated virus transmission event led us to
investigate whether a natural mutant virus had arisen during the
course of this experiment.
Characterization and transmissibility of the H2N2 natural
variant virus
The unique transmission event of an ElSalv/57virus inone ferret
prompted further characterization of the virus that was shed on day
7 p.c. It should be noted that this transmission event occurred
unusually late compared to viruses that transmit efficiently in this
model [15,16]. RNA was extracted from virus present in the nasal
wash collected from the contact ferret and was subjected to RT-
PCR and sequence analysis. Sequence analysis identified a natural
variant (designated ElSalv/57-Q226L) possessing a single amino
Pandemic H2N2 Transmission
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leucine (L) at position 226. Amino acid position 226 of the H2 HA
represents a keyresidue that influencesbindingto SA [20,21,26,27].
Only two other amino acid changes occurred in the ElSalv/57-
Q226L virus HA, one on the HA1 portion of the molecule at
position 16; a change from alanine (A)to valine (V)(H3numbering),
and a second change located on the HA2 at position 460, a change
from aspartic acid (D) to asparagine (N). Both changes map to
regions of unassigned functions within the HA protein.
The HA of ten to twelve plaque-purified viruses derived from
the nasal washes of all three ElSalv/57 inoculated ferrets were
sequenced. Although a heterogeneous distribution of viruses with
different receptor binding specificities was detected, no virus
displaying the variant L226/G228 genotype was isolated from the
virus-donor inoculated ferret (Ferret #3) (Table 2; receptor
binding specificity characterized using RBC agglutination (Figure
S1 and Table S1). Instead, a combination of Q226/G228 and
Q226/S228 was present in a 1:1 proportion in the nasal washes
collected on days four and six p.i. (Table 2). Virus from nasal wash
collected earlier in infection (day 2 p.i.), revealed that all three
ElSalv/57-inoculated ferrets had the same Q226/G228 amino
acid combination as the ElSalv/57 wild type virus, suggesting that
a G228S mutation occurred in ferret #3 after inoculation.
Screening of plaque purified viruses from the two remaining
inoculated ferrets (days four and six p.i.) that did not transmit virus
revealed that their amino acid combination was either identical to
ElSalv/57 wild type virus (Ferret #1), or a combination of Q226/
G228 and Q226/S228 in a proportion of 1:9 (Ferret #2) (Table 2).
Figure 1. Respiratory droplet and direct contact transmission experiments using avian H2N2 virus. For each experiment, three ferrets
were inoculated intranasally (i.n.) with 10
6 EID50 of Mallard/78 virus and placed in individual cages. A: Twenty four hours later, one naı ¨ve ferret was
housed in a cage adjacent to each of the cages containing an inoculated ferret (respiratory droplet transmission), separated by perforated walls to
allow the exchange of respiratory droplets. B: For direct transmission experiments, one naı ¨ve ferret was housed in the same cage with the inoculated
ferret. Nasal wash samples were collected from the inoculated and contact ferrets on alternating days and titered in eggs. Bars with the same color
represent an inoculated/contact ferret pair. The limit of virus detection was 10
1.5 EID50/ml.
doi:10.1371/journal.pone.0011158.g001
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its ability to transmit by respiratory droplets. Similar to previous
transmission experiments, three ferrets were inoculated with10
6
EID50/ml of ElSalv/57-Q226L virus. ElSalv/57-Q226L-infected
ferrets exhibited peak mean nasal wash titers on day 2 p.i. (EID50/ml=
10
6.25), similar to titers achieved in ferrets inoculated with the wild type
ElSalv/57 virus (Table 1). However, in contrast to wild type ElSalv/57
virus, the ElSalv/57-Q226L virus transmitted efficiently to all naı ¨ve
ferrets (Figure 2E). These results suggest that single amino acid changes
in the receptor binding site of the H2 HA may be sufficient to confer
transmission via respiratory droplets. To understand the differences in
transmissibility with relation to the structural and biochemical
properties of the HA, we next characterized the glycan receptor
binding preference of the avian and human (wild-type and natural
HA variants) H2 viruses using RBC agglutination and glycan array
methodologies.
Glycan-receptor binding specificity of H2 viruses from
1957/58 pandemic
The recently solved X-ray co-crystal structures of avian and
human H2 HAs with representative a2,3 and a2,6 SA liked glycan
receptors [26] provides insights into the key amino acids involved in
optimal contacts with these receptors (Figure 3). In addition to the
conserved residues that bind to the SA – Ser/Thr136, Trp153,
Thr155,His183,Glu190,Leu194(numberingisbasedonH3HA)–
the key residue positions that are involved in making contacts with
the other sugars of the glycan receptors are shown in Table 3.
Among these positions (numbered based on H3 HA), amino acids at
137, 222, 226, 228 are involved in making contacts with the SA and
the penultimate Gal sugar in both a2,3 and a2,6 glycan receptors.
On the other hand, amino acids at 156, 189, 192 and 193 are either
directly or indirectly involved in making contacts with additional
sugars at the reducing end the penultimate Gal of an a2,6 SA linked
tetra-pentasaccharide (for example multiple lactosamine repeats
terminated by a2,6 SA) (Figure 3).
Examination of the HAsequencesofthethree H2N2 virusesused
in this study reveal differences in the glycan receptor-binding site.
The primary differences in the H2N2 viruses are at positions 226
and 228 of HA. While the Alb/58 virus possesses L226 and S228,
both ElSalv/57 and the avian H2N2 Mallard/78 virus have Q226
and G228 inthese positions(Table 3).L226 and S228 make optimal
contacts with SA a2,6-linked to the Gal of a human glycan receptor
[26]. Among these two residues L226 plays a crucial role in
preferentially binding to the a2,6-linked as compared to a2,3-linked
SA. Based on these amino acid differences in the glycan receptor
binding site of the H2 HAs, Alb/58 virus was expected to have a
predominantbindingpreferencetoa2,6ascomparedtoa2,3glycan
receptors. Onthe otherhand,both ElSalv/57and Mallard/78were
likely to preferentially bind a2,3 over a2,6 glycan receptors. The
hypothesized binding properties were tested experimentally.
A hemagglutination assay with H2 viruses binding to turkey red
blood cells (RBCs) resialylated with either a2-3 or a2-6 linked
sialosides was used as a preliminary screen of receptor specificity
(Figure S1, Table S1). Alb/58 and Mallard/78 viruses were found
to agglutinate both a2,6 and a2,3 sialylated RBCs, in contrast to
the binding properties observed in a previous study that used a
solid-phase receptor binding assay [24]. The differential hemag-
glutination titers achieved suggested that Alb/58 virus possessed
stronger binding preference for a2,6 SA in comparison to a2,3 SA
receptors, whereas Mallard/78 virus appeared to possess compa-
rable preference for both receptors in this assay (Table S1).
However, ElSalv/57 virus preferentially agglutinated a2,3 sialy-
lated RBCs over a2,6 sialylated RBCs, consistent with previous
studies [24]. The natural variant (Q226L HA mutant) of ElSalv/
57 virus showed preferential agglutination of a2,6 sialylated RBCs
as compared to a2,3 sialylated RBCs.
Previously we demonstrated that high relative binding affinity of
HA to a2,6 glycan receptors with a characteristic structural
topology is an important determinant for human adaptation of
influenza A viruses [17]. Given the observed differences in the
Table 1. Clinical signs, virus replication, seroconversion, and transmission in ferrets inoculated with H2N2 viruses.
Number of inoculated ferrets/total number
Number of contact
ferrets/total number
Clinical Signs
Mean nasal
wash titer
log10EID50/ml
(peak day)
Seroconversion
(HI range)**
Virus detected
in nasal wash
Seroconversion
(HI range)**
Virus
Receptor
binding
specificity
Mean
Maximum
Weight
Loss (%)*
Sneezing
(day(s) of
onset)
Lethargy
(day of
onset)
Mallard/78 (RD)
p a2,3/2,6 3.5 0/3 0/0 7.3 (4) 3/3 (80–160) 0/3 0/3
Mallard/78 (DC)
" 4.8 1/3 (4) 0/0 6.25 (2) 3/3 (80–160) 1/3 1/3 (320)
Alb/58 (RD) a2,6/2,3 7 3/3 (4–6) 0/0 6.2 (2) 3/3 (320–640) 3/3 3/3 (320–640)
Alb/58 (DC) 9 2/3 (3–7) 2/3 (3) 5.9 (2) 2/2 (320) 3/3 3/3 (320)
ElSalv/57 (RD) a2,3 7.2 1/3 (4) 1/3 (4) 6.5 (2) 3/3 (320) 1/3 1/3 (160)
ElSalv/57 (DC) 4.5 0/0 2/3 7.0 (2) 3/3 (320) 0/3 1/3 (640)
El Salv/57-Q226L (RD) a2,6 2.6 1/3 (7) 1/3 (7) 6.25 (2) 3/3 (320–640) 3/3 2/3 (160–640)***
RD, respiratory droplet; DC, direct contact transmission; ND, not determined.
pThis experiment was performed using virus that was obtained from plaque purification and grown in MDCK cells.
"These experiments were done independently from the first one, using virus that was grown in allantoic fluid of 10-day old embryonated eggs.
*The percentage corresponds to the ferrets that exhibited highest drop in weight during the experiment.
** Hemagglutination inhibition (HI) titer is shown. Performed with homologous virus and turkey red blood cells.
*** The lack of seroconversion in one of the ferrets is explained by the short window span between late peak of virus detection and sera sample collection.
doi:10.1371/journal.pone.0011158.t001
Pandemic H2N2 Transmission
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natural variant), we analyzed in detail the direct binding of these
viruses in a dose-dependent fashion to a glycan array comprised of
structurally well-defined a2,3 and a2,6 oligosaccharides. For this
analysis, five glycans were used that differ in their linkage, length
and characteristic structural topology as described previously [17].
Table 2. Composition of amino acids responsible for receptor binding among plaque purified viruses obtained from ferret nasal
washes.
Inoculated Ferrets Contact Ferrets
Position 226 (codon)
Number/total**
Position 228 (codon)
Number/total**
Receptor
Binding
Specificity
Position 226
(codon)
Number/total
Position 228
(codon)
Number/total
Receptor
Binding
Specificity
Input virus (used
for inoculation)
Q (CAA) 10/10 G (GGT) 10/10 a 2,3 - - -
Ferret #1 Q (CAA) 10/10 G (GGT) 10/10 a 2,3 ND* ND* -
Ferret # 2 Q (CAA) 10/10 G (GGT) 1/10
S (AGT) 9/10
a 2,3
none
ND* ND* -
Ferret #3 Q (CAA) 12/12
" G (GGT) 6/12
S (AGT) 6/12
a 2,3
none
L (CTA) 10/10 G (GGT) 10/10 a 2,6
* No detectable ElSalv/57 virus was isolated from nasal washes (day 6 p.i.) during a respiratory droplet transmission experiment.
** Refers to the number of plaque purified viruses containing that specific codon in relation to the number of numbers of plaque purified viruses that were analyzed by
nucleotide sequencing.
"Same results were obtained in the nasal wash samples collected on day 4 p.i.
doi:10.1371/journal.pone.0011158.t002
Figure 2. Respiratory droplet and direct contact transmission experiments using human H2N2 viruses. For each experiment, three
ferrets were inoculated i.n. with 10
6 EID50 of Albany/58, El Salv/57 or El Salv/57-Q226L mutant. Each ferret was placed in individual cages. A, C and E:
Twenty four hours later, one naı ¨ve ferret was housed in a cage adjacent to each of the cages containing an inoculated ferret (respiratory droplet
transmission), separated by perforated walls to allow the exchange of respiratory droplets. B and D: For direct transmission experiments, one naı ¨ve
ferret was housed in the same cage with the inoculated ferret. Nasal wash samples were collected from the inoculated and contact ferrets on
alternating days and titered by EID50. Bars with the same color represent an inoculated/contact ferret pair. The limit of virus detection was 10
1.5 EID50/
ml. {, ferret found dead on day 8 p.i.
doi:10.1371/journal.pone.0011158.g002
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a2,3 glycans (Figure 4, Table S2). The substantial binding of a
human influenza virus to glycans with a2-3 SA is notable since this
pattern is generally not characteristic of human-adapted influenza
H1 and H3 subtype viruses, including the 1918 (SC/18:H1N1)
and 1968 (H3N2) pandemic strains [13,17,24]. However, the
Figure 3. Structural model of human H2N2 viruses with a2,6 receptor. A, Stereo view of homology based structural model of Alb/58 HA
complexed with a2,6 oligosaccharide. This model was constructed using a representative human H2N2 HA – a2,6 receptor co-crystal structure (PDB
ID: 2WR7) as template. The optimal contact between the critical Leu226 with the C6 atom of SA a2,6-linked to Gal motif is shown with dashed line. B,
Stereo view of homology based structural model of ElSalv/57 HA complexed with a2,6 oligosaccharide. This model was constructed using an avian-
like H2N2 HA (PDB ID: 3KU3) as template. The main differences in contacts between A and B are in positions 226 and 228 that make contacts with SA
a2,6-linked to the penultimate Gal and in 156 position that makes contacts with additional sugars at the reducing end of penultimate Gal. The sugar
is shown as a stick representation colored by atom (carbon in orange, oxygen in red and nitrogen in blue). The homology based structural models
were constructed as described previously [18].
doi:10.1371/journal.pone.0011158.g003
Table 3. Composition of the hemagglutinin receptor binding amino acids and residues that interact with a2-3 and a2-6 glycans.
Amino Acid Position (H3 numbering)
137 156 189 192 193 222 226 228
Consensus Human H2N2 1962–1968 K K A R A K/E* L S
Consensus Human H2N2 1957–1961 R K T R T K L/Q** S/G**
Consensus Avian H2N2 RKA / T * RTK Q G
Alb/58 RKT RTK L S
ElSalv/57 RKT RTK Q G
Mallard/78 RKT RTK Q G
Consensus sequences from human H2N2 viruses that circulated during pandemic, H2N2 avian viruses and from the viruses used in this study.
*More than one amino acid is shown in cases where the proportion of viruses containing it was higher than 30%.
**Receptor binding amino acids 226Q228G and 226Q228S could be found in the viruses that circulated during this period.
doi:10.1371/journal.pone.0011158.t003
Pandemic H2N2 Transmission
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69SLN-LN) as compared to a2,3 glycans over the entire range of
viral titers demonstrated the high relative binding affinity of Alb/
58 virus to a2,6 glycans. On the other hand, ElSalv/57 virus
showed preferential binding to a2,3 oligosaccharides over a2,6
oligosacharides (Figure 4). The binding of the ElSalv/57 natural
variant (carrying the Q226L HA mutation) showed predominant
binding signals to a2,6 and only minimal binding signals to a2,3
glycan receptors (Figure 4). Comparison of the a2,6 binding
signals over the entire viral titer range between Alb/58 and the
ElSalv/57 natural variant viruses shows that Alb/58 virus has a
higher a2,6 binding affinity than the natural variant.
The above experimental binding data support the predicted
binding properties of the H2N2 viruses based on structural and
sequence analysis of the glycan receptor binding sites on the HA.
Furthermore, the a2,6 binding affinity of ElSalv/57 and Alb/58
human H2N2 viruses correlates with their observed transmissibil-
ity via respiratory droplets to naı ¨ve ferrets. The improved
respiratory droplet transmissibility of the natural variant of
ElSalv/57 virus correlates with the dramatic increase in its
binding specificity to a2,6 glycan receptors.
Discussion
The factors leading to the emergence of a pandemic influenza
virus are complex and poorly understood. An understanding of the
molecular and biologic requirements for efficient transmissibility is
critical for the early identification of a potential pandemic virus
and the application of optimal control measures. Despite the fact
that an H2N2 virus was responsible for a major pandemic in the
20
th century, the absence of this subtype in the human population
in the last 40 years has resulted in the H2 subtype receiving little
attention. Moreover, the proportion of humans that lack serologic
immunity to the H2 subtype is ever expanding. Thus, if a
contemporary avian H2 virus were to jump the species barrier and
acquire the ability to undergo efficient and sustained transmission
among humans, the conditions could be set for an influenza
epidemic or even pandemic. Our study is the first to characterize
the transmission of H2N2 pandemic viruses in mammals and
reestablish the relationship between transmissibility and glycan-
receptor binding properties of these viruses.
The efficient transmission of Alb/58 virus was consistent with
ferret transmission results obtained for other known human
influenza viruses, including the 1918 (SC/18:H1N1) pandemic
virus [13,15]. In contrast, ElSalv/57, another H2N2 virus isolated
from human host did not transmit efficiently. However, isolation
and characterization of the natural variant (ElSalv/57-Q226L)
isolated from the nasal wash of the contact ferret revealed a
receptor binding site (Q226L) mutation in the HA. The amino
acids at positions 226 and 228 have been implicated to play an
important role in distinguishing a2,3 and a2,6 glycan receptors
[24]. Furthermore, when this natural variant obtained from nasal
wash of the contact ferret was plaque purified and further tested
this virus demonstrated substantially improved transmission via
respiratory droplet as compared to the parental ElSalv/57 virus.
In the ferret model, efficient respiratory droplet transmission of
avian influenza viruses with a a2,3 SA receptor binding preference
has not been observed [15,16]. Furthermore, mutations in HA
that enable a switch from the human a2,6 to the avian a2,3 SA
receptor binding preference result in a virus incapable of
respiratory droplet transmission [13]. Characterization of the
glycan-binding preference of the H2N2 viruses showed that the
avian H2N2 virus, Mallard/78, and the ElSalv/57 virus
preferentially bound to a2,3 glycan receptors. The dual binding
of Mallard/78 to both types of receptors could be explained by
recent results that showed the ability of avian H2 HA to bind to
both human and avian receptors (Figure 3 and [26]). The
inefficient transmission of these viruses is consistent with the
previously established relationship between a2,3 glycan-receptor
binding preference and poor transmission of avian-adapted H1,
H5, H7 and H9 viruses [14,15,16,28]. The Alb/58 virus showed
dual binding to both a2,6 and a2,3 glycan receptors with its a2,6-
binding affinity substantially higher than its a2,3-binding affinity
(as observed in dose-dependent direct glycan array binding assay).
This binding pattern is different from the one obtained with the
1918 (SC/18:H1N1) pandemic strain, which binds exclusively to a
specific subset of a2,6 sialylated oligosaccharides (including
69SLN-LN) [17]. Nevertheless, the efficient transmission of Alb/
58 virus was consistent with ferret transmission results of human
influenza viruses, including the 1918 (SC/18:H1N1) pandemic
virus [13,29]. While some mixed binders such as the 1918 HA
variant A/New York/1/1918 or A/Hong Kong/213/03 (H5N1)
virus do not transmit efficiently [13,30], other mixed binders like
A/Texas/36/91 (H1N1) virus do spread efficiently [13] thereby
deomonstrating that mixed binding does not necessarily disqualify
a virus from transmission. Analysis of the glycan-binding specificity
of the natural variant of the ElSalv/57 virus that carries the
Q226L mutation in the HA showed a dramatic shift in the glycan
binding specificity to a2,6 glycan receptors in comparison with its
parental virus. These results contrast with the recent results of Xu
et al. [25], which observed that H2 HA 226L/228G produce weak
binding to both a2,6 and a2,3 linked glycans. In the current study,
the increase a2,6 glycan-binding specificity of ElSalv/57 virus
correlated with the increased respiratory droplet transmission to
naı ¨ve ferrets.
Based on the transmission data obtained on multiple avian and
human-adapted viruses over the past several years it is improbable
that an influenza virus possessing a strong a2,3 SA receptor
preference would spread efficiently among humans [13,16].
Nevertheless, the question still remains of whether H2N2 viruses
with a2,3 SA receptor binding specificity were circulating early in
the pandemic [20,24,31]. Assessing this possibility includes
providing an understanding of whether and how these early-
circulating viruses could switch receptor binding specificity. Such
studies may provide additional information on the mechanisms of
how influenza could adapt to a new host. Notably, Alb/58, a
human-adapted and high passage virus, seemingly possesses a2,3
glycan-binding, in addition to a2,6 SA binding; this double
binding feature has previously been noted for H2N2 viruses [20].
Although a number of H2N2 pandemic viruses possessed a2,3 SA
receptor preference, internal genes from these viruses (including
the natural variant ElSalv/57-Q226L identified here) possess
characteristics of human-adapted viruses. In particular, the H2N2
pandemic virus possessed a human adapted PB2 gene. Adaptation
of the PB2 also appears to be critical for efficient aerosolized
Figure 4. Glycan binding of Alb/58, ElSalv/57, and A/El Salv/57-Q226L viruses. The binding signals are expressed as percentage of
maximum binding of each virus to the glycan arrays. At saturating HA titers, both Alb/58 and A/El Salv/57-Q226L showed binding signals to long and
short a2-6 glycans, but Alb/58 also showed high binding signals to long and short a2-3 glycans. ElSalv/57 virus showed binding affinity to all three
types of a2-3 glycans but also displayed some binding to long a2-6 glycans at higher titers. The types of glycans used on the arrays are described
(Table S2).
doi:10.1371/journal.pone.0011158.g004
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single amino acid substitution from glutamic acid to lysine at
amino acid position 627 supports efficient influenza virus
replication at the lower temperature (33uC) found in the
mammalian airway, and contributes to efficient transmission in
ferrets and guinea pigs.
In our study, many of the plaque-purified viruses obtained from
the three inoculated ferrets nasal washes collected later in the
course of infection did not show a homogeneous population at
amino acids 226 and 228. Thus, the different residues within
receptor binding site of the H2 HA appear to confer a selective
advantage by enabling a receptor specificity switch allowing for
transmission of a variant virus. Given these results, the receptor
binding site of the H2 HA appears to be genetically unstable
allowing the virus to switch its binding preference during
replication. Finally, because the avian and human-adapted
H2N2 viruses that were isolated early in the pandemic share
similarities in their glycan-binding amino acids (Table 3), we
hypothesize based on our results that these amino acids provide a
molecular framework that allows the easy switch of their receptor
binding preferences. Together with changes in PB2, these HA
changes allow for efficient transmission of virus in a human
host.
Materials and Methods
Viruses
H2N2 viruses were provided by the Viral Surveillance and
Diagnostic Branch (VSDB), CDC. Original human H2N2 virus
isolates or low-egg-passage isolates are not available for study. A/
Mallard/New York/6750/78 (Mallard/78) was previously pas-
saged seven times in embryonating hen’s eggs and two times in
chicken kidney cells; the virus stock used for the experiments was
plaque purified and grown in Madin-Darby canine kidney
(MDCK) cells [32]. A/Albany/6/58 (Alb/58) virus was passaged
nine times in hen’s eggs; the virus stock was grown in the allantoic
cavity of 10–11 day old hen’s eggs. GenBank accession numbers
for Mallard/78 and Alb/58 viruses are available from http://
www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html. A/El Salvador/
2/57 (El Salv/57; GenBank accession no. submitted) virus had been
previously passaged eight times in eggs and virus stock was grown in
MDCK cells. El Salv/57-Q226L virus (GenBank accession no.
submitted) was obtained by plaque purification from the nasal wash
of a contact ferret during a transmission experiment and grown in
MDCK cells. The EID50 titer for each stock was calculated by the
method of Reed and Muench following serial titration in eggs [33].
The PFU titer for each cell-grown stock was also determined by
standard plaque assay [34]. Viruses were confirmed by RT-PCR
and sequencing. Comparisons between parental ElSalv/57 and El
Salv/57-Q226L viruses’ entire genomes revealed two amino acid
changes in the HA (A24V in HA1 and D135N in HA2), two
changes in the neuraminidase (V20A and F22L) and three changes
in the matrix protein (R57K, G105R and S224R). Research with
H2 viruses was conducted under biosafety level 3 containment,
including enhancements required by the U.S. Department of
Agriculture/CDC Select Agent Program.
Ethics Statement
All animal research described in this study was specifically
approved by CDC’s Institutional Animal care and Use Committee
(IACUC). The animal research was conducted under the guidance
of CDC’s IACUC and in an Association for Assessment and
Accreditation of Laboratory Animal Care International-accredited
facility.
Ferret Transmission Experiments
Male Fitch ferrets 6–12 months of age (Triple F Farms, Sayre,
PA) were used in transmission studies. Ferrets were housed
throughout each experiment in cages within a Duo-Flo Bioclean
mobile clean room (Lab Products, Seaford, DE) and were
determined to be negative for antibody to circulating influenza
A (H1N1, H3N2) and Influenza B viruses. Ferrets were inoculated
with 10
6 PFU or EID50 of virus in a total volume of 1 ml (500 mL/
nostril) as described [32]. Respiratory droplet and contact
transmission experiments were conducted as previously described
[16]. Briefly, 24 hours after inoculation, uninfected ferrets were
housed in either adjacent transmission cages (respiratory droplet
transmission) or in the same cage (direct contact transmission).
Temperature, weight and clinical symptoms were recorded daily
for 14 days. During this period, nasal washes were collected every
two days for determination of viral titers in both inoculated and
contact ferrets. Convalescent serum from all ferrets was collected
days 18–21 p.i./p.c. and tested for H2 HA antibodies by using
homologous virus and 0.5% turkey or 1% horse red blood cells as
described [35].
Hemagglutination Assays
Hemagglutination assays using resialyated turkey red blood cells
were performed as previously described [34,36] with minor
modifications. Turkey red blood cells were enzymatically desia-
lyated followed by resialylation using either a2-6-(N)-sialyltrans-
ferase (Japan Tobacco Inc, Iwata, Japan) or a2-3-(N)-sialyltrans-
ferase (Calbiochem, San Diego, CA). Assays were performed by
using both 4 and 8 hemagglutination units of virus yielding
identical results.
Dose dependant direct binding assay
Virus stocks were propagated in the allantoic cavity of 10-d-old
embryonated hens’ eggs at 37uC. The allantoic fluids were
harvested 24 h after inoculation and inactivated by treatment with
Beta-propiolactone (BPL; 1/1,000) for 3 days at 4uC. Virus
binding to the glycan-coated wells was performed as described
previously [17] by adding appropriate amount of virus to each well
after diluting in PBS containing 1% BSA and incubating overnight
at 4uC. After rinsing excess virus with PBS containing 0.05%
Tween-20 and PBS, the wells were incubated with antibody
against the virus (ferret-anti-influenza A raised against El Salv/57
and Alb/58) for 5h at 4uC. After extensive washing of the
antibody, the plate was incubated with HRP-linked goat-anti-
ferret antibody (Rockland Immunochemicals) for 2 h at 4uC. After
extensive washes with PBS containing 0.05% Tween-20 and PBS,
in all cases, HRP activity was estimated using Amplex Red
Peroxidase Assay Kit (Invitrogen) according to manufacturer’s
instructions. Appropriate negative controls were included.
Supporting Information
Figure S1 Receptor binding specificities using RBC agglutina-
tion. Hemagglutination assay using turkey red blood cells (tRBCs)
resialylated with either a2,3 or a2,6 sialyl transferases. A/Texas/
36/1991 and A/Duck/NY/15024/1996 were used as human and
avian controls, respectively. Turkey red blood cells were
enzymatically desialyated followed by resialylation using either
a2-6-(N)-sialyltransferase (Japan Tobacco Inc, Iwata, Japan) or a2-
3-(N)-sialyltransferase (Calbiochem, San Diego, CA). Assays were
performed by using 8 hemagglutination units of virus.
Found at: doi:10.1371/journal.pone.0011158.s001 (2.04 MB
DOC)
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present in the hemagglutinin of H2N2 viruses used in this study
and their receptor binding specificity. The viruses were assayed by
hemagglutination using resialylated turkey red blood cells (RBCs).
Found at: doi:10.1371/journal.pone.0011158.s002 (0.04 MB
DOC)
Table S2 Glycans used on arrays for detecting long and short
a2-3/a2-6 sialylated chains. Key: Neu5Ac: N-acetyl D-neur-
aminic acid; Gal: D-galatose; GlcNAc: N-acetyl D-glucosamine.
a/b: anomeric configuration of the pyranose sugars. All the
sugars are linked via a spacer to biotin (-Sp-LC-LC-Biotin
as described in http://www.functionalglycomics.org/static/
consortium/resources/resourcecored5.shtml).
Found at: doi:10.1371/journal.pone.0011158.s003 (0.07 MB
DOC)
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